Mark For: KYNBRAVA™ trademark registration is intended to cover the categories of pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes; pharmaceutical preparations to treat inflammatory diseases and disorders and diseases and disorders of the immune system; pharmaceutical preparations to treat dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis.
Status
2023-01-22 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
No
Filed ITU
No
44D Filed
Yes
44E Current
Yes
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Joyce M. Ferraro
Attorney Docket Number
ROIV 2301301
Timeline
2023-01-09
Trademark Registered
2023-01-18
Application Filed
2023-01-21
Location: NEW APPLICATION PROCESSING
2023-01-21
Status: Live/Pending
2023-01-21
Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
JOYCE M. FERRARO FROSS ZELNICK LEHRMAN & ZISSU, P.C. 151 WEST 42ND STREET, 17TH FLOOR NEW YORK, NY 10036
Good, Services, and Codes
International Codes:
5
U.S. Codes:
005,006,018,044,046,051,052
Type Code
Type
GS0051
Pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes; pharmaceutical preparations to treat inflammatory diseases and disorders and diseases and disorders of the immune system; pharmaceutical preparations to treat dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis
GS0051
Pharmaceutical preparations to treat Crohn's Disease for human use; biologic preparations for medical and therapeutic purposes to treat Chron's disease, inflammatory diseases and disorders, diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis; pharmaceutical preparations to treat inflammatory diseases and disorders and diseases and disorders of the immune system; pharmaceutical preparations to treat dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis
Trademark Filing History
Description
Date
Proceeding Number
NEW APPLICATION ENTERED
2023-01-21
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.